← Leaderboards
Naga P. Chalasani
Indiana University Indianapolis
$27,144,645
Attributed
$35,168,732
Total exposure
30
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,168,732 · 30
By mechanism
U01$24,728,490 · 3
R01$8,807,002 · 2
K24$1,395,469 · 1
M01$166,609 · 23
R03$71,162 · 1
Top collaborators
- David W Crabb7 shared
- Rohit Loomba5 shared
- Mark Sebastian Sulkowski5 shared
- Olawale Ojo2 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Roland W. Herzog$25,146,618
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchResearch PersonnelFundingAdultLiverPathogenesisRandomizedIndianaUniversitiesMeetingsChildEnrollmentLiver DiseasesProspectiveFatty LiverAncillary StudyRisk FactorsData Coordinating CenterPlacebosDatabasesBaseNonalcoholic SteatohepatitisPilot ProjectsSource
Grant awards (129)
IU Clinical Center: Drug Induced Liver Injury Network$385,250
U01 · FY2025 · DK · contact PI
Integrated therapies for alcohol use and ALD (ITAALD) Network - IU Clinical Center$343,316
U01 · FY2025 · AA · contact PI
Collaborative Clinical Research in Nonalcoholic Steatohepatitis$249,999
U01 · FY2025 · DK · contact PI
Ancillary Studies of NAFLD and NASH in HIV infected Adults$1,464,756
R01 · FY2024 · DK · contact PI
Integrated therapies for alcohol use and ALD (ITAALD) Network - IU Clinical Center$348,700
U01 · FY2024 · AA · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$334,081
U01 · FY2024 · DK · contact PI
Collaborative Clinical Research in Nonalcoholic Steatohepatitis$250,000
U01 · FY2024 · DK · contact PI
Ancillary Studies of NAFLD and NASH in HIV infected Adults$1,542,615
R01 · FY2023 · DK · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$376,579
U01 · FY2023 · DK · contact PI
Collaborative Clinical Research in Nonalcoholic Steatohepatitis$242,883
U01 · FY2023 · DK · contact PI
Ancillary Studies of NAFLD and NASH in HIV infected Adults$1,558,981
R01 · FY2022 · DK · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9$493,454
U01 · FY2022 · AA · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$348,402
U01 · FY2022 · DK · contact PI
Collaborative Clinical Research in Nonalcoholic Steatohepatitis$235,419
U01 · FY2022 · DK · contact PI
Ancillary Studies of NAFLD and NASH in HIV infected Adults$1,566,039
R01 · FY2021 · DK · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9$522,511
U01 · FY2021 · AA · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$324,150
U01 · FY2021 · DK · contact PI
Collaborative Clinical Research in Nonalcoholic Steatohepatitis$290,419
U01 · FY2021 · DK · contact PI
Ancillary Studies of NAFLD and NASH in HIV infected Adults$1,703,139
R01 · FY2020 · DK · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9$375,894
U01 · FY2020 · AA · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$348,496
U01 · FY2020 · DK · contact PI
Collaborative Clinical Research in Nonalcoholic Steatohepatitis$300,419
U01 · FY2020 · DK · contact PI
Collaborative Clinical Research in Nonalcoholic Steatohepatitis$331,538
U01 · FY2019 · DK · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9$225,496
U01 · FY2019 · AA · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$196,287
U01 · FY2019 · DK · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9$155,575
U01 · FY2019 · AA · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9$368,841
U01 · FY2018 · AA · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$340,025
U01 · FY2018 · DK · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$236,502
U01 · FY2018 · DK · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 2/9$9,891
U01 · FY2018 · AA · contact PI
Collaborative Clinical Research on Hepatotoxicity$355,040
U01 · FY2017 · DK · contact PI
Collaborative Clinical Research on Hepatotoxicity$323,357
U01 · FY2017 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$260,329
U01 · FY2017 · DK · contact PI
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)$226,211
U01 · FY2017 · AA
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)$862,255
U01 · FY2016 · AA
Collaborative Clinical Research on Hepatotoxicity$377,462
U01 · FY2016 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$268,137
U01 · FY2016 · DK · contact PI
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)$918,831
U01 · FY2015 · AA
Collaborative Clinical Research on Hepatotoxicity$470,976
U01 · FY2015 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$299,360
U01 · FY2015 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$174,712
U01 · FY2015 · DK · contact PI
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)$1,006,217
U01 · FY2014 · AA
Collaborative Clinical Research on Hepatotoxicity$338,844
U01 · FY2014 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$163,837
U01 · FY2014 · DK · contact PI
Patient-Oriented Research of Liver Disease$139,676
K24 · FY2014 · DK · contact PI
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)$66,805
U01 · FY2014 · AA
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)$880,013
U01 · FY2013 · AA
Collaborative Clinical Research on Hepatotoxicity$284,969
U01 · FY2013 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$271,637
U01 · FY2013 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$206,348
U01 · FY2013 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$199,275
U01 · FY2013 · DK · contact PI
Patient-Oriented Research of Liver Disease$139,676
K24 · FY2013 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$106,316
U01 · FY2013 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$59,217
U01 · FY2013 · DK · contact PI
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)$948,453
U01 · FY2012 · AA
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$628,215
U01 · FY2012 · DK · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$310,297
U01 · FY2012 · DK · contact PI
Patient-Oriented Research of Liver Disease$139,676
K24 · FY2012 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$583,895
U01 · FY2011 · DK · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$303,423
U01 · FY2011 · DK · contact PI
Patient-Oriented Research of Liver Disease$139,676
K24 · FY2011 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$576,031
U01 · FY2010 · DK · contact PI
Nonalcoholic steatohepatitis and Cytochrome P450 Enzymes$234,404
R01 · FY2010 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$217,662
U01 · FY2010 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$144,778
U01 · FY2010 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$144,236
U01 · FY2010 · DK · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$140,103
U01 · FY2010 · DK · contact PI
Patient-Oriented Research of Liver Disease$137,181
K24 · FY2010 · DK · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$102,400
U01 · FY2010 · DK · contact PI
Patient-Oriented Research of Liver Disease$34,938
K24 · FY2010 · DK · contact PI
Collaborative Clinical Research on Non Alcoholic Stratohepatitis$243,743
U01 · FY2009 · DK · contact PI
Nonalcoholic steatohepatitis and Cytochrome P450 Enzymes$237,390
R01 · FY2009 · DK · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$196,910
U01 · FY2009 · DK · contact PI
Patient-Oriented Research of Liver Disease$140,510
K24 · FY2009 · DK · contact PI
Nonalcoholic steatohepatitis and Cytochrome P450 Enzymes$244,154
R01 · FY2008 · DK · contact PI
Patient-Oriented Research of Liver Disease$136,417
K24 · FY2008 · DK · contact PI
Clinical Research on Non-Alcoholic Steatohepatitis$98,702
U01 · FY2008 · DK · contact PI
IU Clinical Center: Drug Induced Liver Injury Network$68,212
U01 · FY2008 · DK · contact PI
PIOGLIATAZONE VERSUS VITAMIN E VERSUS PLACEBO FOR THE TREATMENT OF NON-DIABETIC$3,301
M01 · FY2008 · RR · contact PI
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$989
M01 · FY2008 · RR · contact PI
MIDODRINE ADMINISTRATION IN RESPONSE TO FUROSEMIDE IN PTS W/CIRRHOTIC ASCITES$654
M01 · FY2008 · RR · contact PI
A MULTI-CENTER, LONGITUDINAL STUDY OF DRUG- AND CAM-INDUCED LIVER INJURY$567
M01 · FY2008 · RR · contact PI
IDIOSYNCRATIC LIVER INJURY ASSOCIATED WITH DRUGS (ILIAD): A RETROSPECTIVE STUDY$44
M01 · FY2008 · RR · contact PI
Clinical Research on Non-Alcoholic Steatohepatitis$673,614
U01 · FY2007 · DK · contact PI
Collaborative Clinical Research on Hepatotoxicity$270,999
U01 · FY2007 · DK · contact PI
Nonalcoholic steatohepatitis and Cytochrome P450 Enzymes$255,524
R01 · FY2007 · DK · contact PI
Patient-Oriented Research of Liver Disease$132,444
K24 · FY2007 · DK · contact PI
PIOGLIATAZONE VERSUS VITAMIN E VERSUS PLACEBO FOR THE TREATMENT OF NON-DIABETIC$38,846
M01 · FY2007 · RR · contact PI
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$11,637
M01 · FY2007 · RR · contact PI
MIDODRINE ADMINISTRATION IN RESPONSE TO FUROSEMIDE IN PTS W/CIRRHOTIC ASCITES$7,701
M01 · FY2007 · RR · contact PI
A MULTI-CENTER, LONGITUDINAL STUDY OF DRUG- AND CAM-INDUCED LIVER INJURY$6,673
M01 · FY2007 · RR · contact PI
IDIOSYNCRATIC LIVER INJURY ASSOCIATED WITH DRUGS (ILIAD): A RETROSPECTIVE STUDY$512
M01 · FY2007 · RR · contact PI
Clinical Research on Non-Alcoholic Steatohepatitis$623,614
U01 · FY2006 · DK · contact PI
Collaborative Clinical Research on Hepatotoxicity$181,800
U01 · FY2006 · DK · contact PI
Patient-Oriented Research of Liver Disease$128,435
K24 · FY2006 · DK · contact PI
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$22,221
M01 · FY2006 · RR · contact PI
PIOGLIATAZONE VERSUS VITAMIN E VERSUS PLACEBO FOR THE TREATMENT OF NONDIABETI$13,737
M01 · FY2006 · RR · contact PI
A MULTI-CENTER, LONGITUDINAL STUDY OF DRUG- AND CAM-INDUCED LIVER INJURY$7,474
M01 · FY2006 · RR · contact PI
MIDODRINE ADMINISTRATION IN RESPONSE TO FUROSEMIDE IN PTS W/CIRRHOTIC ASCITES$4,444
M01 · FY2006 · RR · contact PI
IDIOSYNCRATIC LIVER INJURY ASSOCIATED WITH DRUGS (ILIAD): A RETROSPECTIVE STU$1,010
M01 · FY2006 · RR · contact PI
Clinical Research on Non-Alcoholic Steatohepatitis$425,922
U01 · FY2005 · DK
Collaborative Clinical Research on Hepatotoxicity$180,600
U01 · FY2005 · DK
Patient-Oriented Research of Liver Disease$126,840
K24 · FY2005 · DK
MIDODRINE ADMINISTRATION IN RESPONSE TO FUROSEMIDE IN PTS W/CIRRHOTIC ASCITES$5,522
M01 · FY2005 · RR
A MULTI-CENTER, LONGITUDINAL STUDY OF DRUG- AND CAM-INDUCED LIVER INJURY$1,105
M01 · FY2005 · RR
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$883
M01 · FY2005 · RR
IDIOSYNCRATIC LIVER INJURY ASSOCIATED WITH DRUGS (ILIAD): A RETROSPECTIVE STU$442
M01 · FY2005 · RR
RACIAL DIFFERENCES IN THE INDUCTION OF CYTOCHROME P 450 3A4 AND 2E1 BY ALCOHOL$221
M01 · FY2005 · RR
Clinical Research on Non-Alcoholic Steatohepatitis$392,240
U01 · FY2004 · DK
Collaborative Clinical Research on Hepatotoxicity$307,704
U01 · FY2004 · DK
Clinical Research on Non-Alcoholic Steatohepatitis$126,260
U01 · FY2004 · DK
Clinical Research on Non-Alcoholic Steatohepatitis$46,088
U01 · FY2004 · DK
Midodrine Administration in Response to Furosemide in Pts w/cirrhotic ascites$23,424
M01 · FY2004 · RR
Racial differences in the induction of cytochrome P 450 3A4 and 2E1 by Alcohol$5,732
M01 · FY2004 · RR
Effect of albumin on furosemide in severely hypoalbuminic cirrhotics w/ascites$5,732
M01 · FY2004 · RR
Metabolic abnormalities in non-alcoholic steatohepatitis$3,738
M01 · FY2004 · RR
Clinical Research on Non-Alcoholic Steatohepatitis$320,000
U01 · FY2003 · DK
Collaborative Clinical Research on Hepatotoxicity$307,704
U01 · FY2003 · DK
Clinical Research on Non-Alcoholic Steatohepatitis$45,975
U01 · FY2003 · DK
Clinical Research on Non-Alcoholic Steatohepatitis$44,635
U01 · FY2003 · DK
Clinical Research on Non-Alcoholic Steatohepatitis$320,000
U01 · FY2002 · DK
ASSESS CYP3A TO METABOLISM OF MIDAZOLAM IN PATIENTS W/ TRANSJUGULAR S$0
M01 · FY2002 · RR
ASSESS CYP3A TO METABOLISM OF MIDAZOLAM IN PATIENTS W/ TRANSJUGULAR S$0
M01 · FY2001 · RR
METABOLIC ABNORMALITIES IN NON-ALCOHOLIC STEATOHEPATITIS$71,162
R03 · FY2000 · DK
ASSESS CYP3A TO METABOLISM OF MIDAZOLAM IN PATIENTS W/ TRANSJUGULAR S$0
M01 · FY2000 · RR
ASSESS CYP3A TO METABOLISM OF MIDAZOLAM IN PATIENTS W/ TRANSJUGULAR S$0
M01 · FY2000 · RR
ASSESS CYP3A TO METABOLISM OF MIDAZOLAM IN PATIENTS W/ TRANSJUGULAR S$0
M01 · FY2000 · RR
ASSESS CYP3A TO METABOLISM OF MIDAZOLAM IN PATIENTS W/ TRANSJUGULAR S$0
M01 · FY2000 · RR
ASSESS CYP3A TO METABOLISM OF MIDAZOLAM IN PATIENTS W/ TRANSJUGULAR S$0
M01 · FY2000 · RR